Trials / Completed
CompletedNCT07415538
Effects of Mulligan SNAG in Chronic Nonspecific Low Back Pain
Effects of Mulligan SNAG Compared With Conventional and Sham Therapy in Chronic Nonspecific Low Back Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Biruni University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized controlled study was to compare the effects of Mulligan SNAG added to conventional physiotherapy with conventional physiotherapy alone and sham SNAG on pain, function, proprioception, and functional performance in individuals with chronic nonspecific low back pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Conventional Physiotherap | Participants in this arm received a standardized conventional physiotherapy program consisting of electrotherapy, thermal modalities, stretching exercises, and core stabilization exercises. The program was administered three times per week for six weeks. |
| OTHER | Conventional Physiotherapy + Mulligan SNAG | Participants in this arm received the same conventional physiotherapy program as the control group, combined with Mulligan Sustained Natural Apophyseal Glide (SNAG) techniques applied to the lumbar spine. SNAG techniques were performed by a physiotherapist during active pain-free movements, three times per week for six weeks. |
| OTHER | Conventional Physiotherapy + Sham SNAG | Participants in this arm received the standardized conventional physiotherapy program combined with sham SNAG applications. The sham procedure mimicked the positioning and therapist-patient interaction of the SNAG technique but without the application of therapeutic glide force. Interventions were administered three times per week for six weeks. |
Timeline
- Start date
- 2026-01-05
- Primary completion
- 2026-02-13
- Completion
- 2026-02-20
- First posted
- 2026-02-17
- Last updated
- 2026-03-02
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07415538. Inclusion in this directory is not an endorsement.